文献速递临床试验与 GCP

儿童打鼾与轻度睡眠呼吸暂停的腺样体扁桃体切除术:一项随机临床试验

Adenotonsillectomy for Snoring and Mild Sleep Apnea in Children: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

这项随机临床试验纳入459名3至12.9岁、打鼾且阻塞性呼吸暂停低通气指数(AHI)低于3的儿童,比较早期腺样体扁桃体切除术与观察等待对神经发育、行为、健康及多导睡眠图结局的影响。12个月时,两组在执行功能和注意力方面无统计学显著差异,但腺样体扁桃体切除术组在行为、症状、生活质量及血压等次要结局上改善更多。

要点

  • 对于轻度睡眠呼吸障碍儿童,腺样体扁桃体切除术在12个月时未显著改善执行功能或注意力。
  • 腺样体扁桃体切除术组在行为问题、嗜睡、症状和生活质量方面改善优于观察等待组。
  • 腺样体扁桃体切除术与收缩压和舒张压百分位水平下降更多相关,且AHI进展至大于3次/小时的比例更低。

核心结论

  • 在轻度睡眠呼吸障碍儿童中,与观察等待相比,腺样体扁桃体切除术在12个月时未显著改善执行功能或注意力,但改善了行为、症状、生活质量等次要结局并降低了血压。

研究设计与样本

  • 随机临床试验,纳入459名3至12.9岁、打鼾且AHI低于3的儿童,来自美国7个学术睡眠中心,2016年6月29日至2021年2月1日入组,随访12个月。
  • 参与者按1:1随机分为早期腺样体扁桃体切除术组(n=231)和观察等待组(n=228)。

主要发现

  • 执行功能(BRIEF GEC T评分)变化:腺样体扁桃体切除术组-3.1 vs 观察等待组-1.9,差异-0.96(95%CI,-2.66至0.74),无统计学显著差异。
  • 注意力(GNG d-prime评分)变化:腺样体扁桃体切除术组0.2 vs 观察等待组0.1,差异0.05(95%CI,-0.18至0.27),无统计学显著差异。
  • 腺样体扁桃体切除术组在行为问题、嗜睡、症状和生活质量方面改善均优于观察等待组。
  • 收缩压百分位水平变化差异-9.02(97%CI,-15.49至-2.54),舒张压百分位水平变化差异-6.52(97%CI,-11.59至-1.45),均为腺样体扁桃体切除术组下降更多。
  • AHI进展至大于3次/小时的比例:腺样体扁桃体切除术组1.3% vs 观察等待组13.2%,差异-11.2%(97%CI,-17.5%至-4.9%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The utility of adenotonsillectomy in children who have habitual snoring without frequent obstructive breathing events (mild sleep-disordered breathing [SDB]) is unknown. OBJECTIVES: To evaluate early adenotonsillectomy compared with watchful waiting and supportive care (watchful waiting) on neurodevelopmental, behavioral, health, and polysomnographic outcomes in children with mild SDB. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial enrolling 459 children aged 3 to 12.9 years with snoring and an obstructive apnea-hypopnea index (AHI) less than 3 enrolled at 7 US academic sleep centers from June 29, 2016, to February 1, 2021, and followed up for 12 months. INTERVENTION: Participants were randomized 1:1 to either early adenotonsillectomy (n = 231) or watchful waiting (n = 228). MAIN OUTCOMES AND MEASURES: The 2 primary outcomes were changes from baseline to 12 months for caregiver-reported Behavior Rating Inventory of Executive Function (BRIEF) Global Executive Composite (GEC) T score, a measure of executive function; and a computerized test of attention, the Go/No-go (GNG) test d-prime signal detection score, reflecting the probability of response to target vs nontarget stimuli. Twenty-two secondary outcomes included 12-month changes in neurodevelopmental, behavioral, quality of life, sleep, and health outcomes. RESULTS: Of the 458 participants in the analyzed sample (231 adenotonsillectomy and 237 watchful waiting; mean age, 6.1 years; 230 female [50%]; 123 Black/African American [26.9%]; 75 Hispanic [16.3%]; median AHI, 0.5 [IQR, 0.2-1.1]), 394 children (86%) completed 12-month follow-up visits. There were no statistically significant differences in change from baseline between the 2 groups in executive function (BRIEF GEC T-scores: -3.1 for adenotonsillectomy vs -1.9 for watchful waiting; difference, -0.96 [95% CI, -2.66 to 0.74]) or attention (GNG d-prime scores: 0.2 for adenotonsillectomy vs 0.1 for watchful waiting; difference, 0.05 [95% CI, -0.18 to 0.27]) at 12 months. Behavioral problems, sleepiness, symptoms, and quality of life each improved more with adenotonsillectomy than with watchful waiting. Adenotonsillectomy was associated with a greater 12-month decline in systolic and diastolic blood pressure percentile levels (difference in changes, -9.02 [97% CI, -15.49 to -2.54] and -6.52 [97% CI, -11.59 to -1.45], respectively) and less progression of the AHI to greater than 3 events/h (1.3% of children in the adenotonsillectomy group compared with 13.2% in the watchful waiting group; difference, -11.2% [97% CI, -17.5% to -4.9%]). Six children (2.7%) experienced a serious adverse event associated with adenotonsillectomy. CONCLUSIONS: In children with mild SDB, adenotonsillectomy, compared with watchful waiting, did not significantly improve executive function or attention at 12 months. However, children with adenotonsillectomy had improved secondary outcomes, including behavior, symptoms, and quality of life and decreased blood pressure, at 12-month follow-up. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02562040.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Redline S, Cook K, Chervin RD, et al. Adenotonsillectomy for Snoring and Mild Sleep Apnea in Children: A Randomized Clinical Trial. JAMA. 2023. PMID: 38051326. doi:10.1001/jama.2023.22114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。